Mycoprotein & fungal biomass

Mycoprotein is the biomass of a filamentous fungus, grown by fermentation and eaten as the food itself rather than purified into an ingredient. It occupies a distinct position among alternative proteins because it solves the texture problem at the level of the organism.

Morphology is the product

Filamentous fungi grow as hyphae — long, branching, thread-like cells. Harvested biomass is therefore already an entangled mass of fibres with dimensions in the same range as animal muscle fibres. Aligning and binding that mass gives a fibrous, chewable texture without high-moisture extrusion, which is what plant-protein routes need a large machine to achieve.

This makes hyphal morphology a process variable to be protected rather than an incidental. Shear in a stirred vessel fragments hyphae; branching frequency and hyphal length respond to growth rate, dissolved oxygen and nutrient limitation. Air-lift fermenters, which circulate broth by injected gas rather than an impeller, are used partly because they impose less mechanical damage on the structure being grown.

Continuous culture, and the limit on it

Fungal biomass is well suited to continuous fermentation: fresh medium is fed and broth withdrawn at a steady rate, so the culture is held in a constant physiological state and productivity per unit volume is high.

The limit is evolutionary. In a long continuous run, spontaneous mutants that grow faster but branch differently — the “highly branched” colonial morphology — are selected for, because selection acts on growth rate, not on the fibre quality the process exists to produce. Run length is therefore bounded by the accumulation of these variants rather than by contamination alone, and the culture must be restarted from stock.

The nucleic acid ceiling

Rapidly growing microbial biomass is rich in RNA, because ribosome content scales with growth rate. Dietary purines from that RNA are metabolised in humans to uric acid, which is poorly soluble; sustained high intake raises the risk of gout and urate stones. This is the reason single-cell protein for human consumption has always faced a consumption ceiling.

The answer is a deliberate processing step: the harvested biomass is heat-shocked, which inactivates proteases faster than ribonucleases, so the cell’s own RNases degrade RNA into nucleotides that diffuse out of the cell while the protein is retained. Nucleic acid content is thereby reduced to a level regarded as safe for regular consumption, conventionally around 2 percent of dry matter.

This step is not optional and not a refinement. It is a safety requirement, it costs biomass yield, and it is the clearest example in the alternative-protein field of a nutritional constraint dictating a unit operation.

What is genuinely contested

Allergy to mycoprotein is documented, and appears to involve sensitisation to fungal proteins; reported reactions are uncommon relative to consumption but real, and cross-reactivity with mould allergy is a plausible route that is not fully characterised. The prudent statement is that this is a recognised and monitored effect whose prevalence is not well established, rather than either a major hazard or a non-issue.

A terminological note: mycoprotein from submerged fungal fermentation, mycelium grown on solid substrate, and harvested mushroom fruiting bodies are three different materials, and figures for one do not describe the others.